Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2009
03/04/2009EP2029592A1 Pharmaceutical compounds
03/04/2009EP2029591A1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
03/04/2009EP2029590A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof
03/04/2009EP2029589A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof
03/04/2009EP2029588A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
03/04/2009EP2029584A2 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use
03/04/2009EP2029583A1 New benzothiazinone derivatives and their use as antibacterial agents
03/04/2009EP2029582A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof
03/04/2009EP2029581A1 P38 inhibitors and methods of use thereof
03/04/2009EP2029580A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
03/04/2009EP2029579A2 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP2029578A1 2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation
03/04/2009EP2029577A2 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
03/04/2009EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP2029575A1 Substituted spirocyclic cgrp receptor antagonists
03/04/2009EP2029574A1 Novel method for preparation of ammonium salts of esomeprazole
03/04/2009EP2029572A2 Organic compounds
03/04/2009EP2029568A1 Flavonoid dimers and methods of making and using such
03/04/2009EP2029566A2 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
03/04/2009EP2029564A2 Treatment for depressive disorders
03/04/2009EP2029562A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
03/04/2009EP2029561A1 Tricyclic compound and pharmaceutical use thereof
03/04/2009EP2029560A2 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors
03/04/2009EP2029559A1 Aryl-4-ethynyl-isoxazole derivatives
03/04/2009EP2029558A2 Compounds and methods for modulating fxr
03/04/2009EP2029556A2 Salts and crystal modifications thereof
03/04/2009EP2029555A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
03/04/2009EP2029553A1 Substituted pyrazinone derivatives for use as a medicine
03/04/2009EP2029552A1 Sulfimides as protein kinase inhibitors
03/04/2009EP2029550A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
03/04/2009EP2029549A2 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
03/04/2009EP2029548A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
03/04/2009EP2029544A1 Pyrrolidine derivatives useful as bace inhibitors
03/04/2009EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors
03/04/2009EP2029542A2 Primary amines as renin inhibitors
03/04/2009EP2029540A2 Benzamide derivatives and uses related thereto
03/04/2009EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
03/04/2009EP2029538A1 Benzylpiperazine derivatives as motilin receptor antagonists
03/04/2009EP2029537A1 Bicyclic tetrahydropyrrole compounds
03/04/2009EP2029536A1 Bicyclic tetrahydropyrrole compounds
03/04/2009EP2029535A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer
03/04/2009EP2029534A2 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
03/04/2009EP2029529A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP2029527A2 Modified chalcone compounds as antimitotic agents
03/04/2009EP2029526A1 Lysine related derivatives as hiv aspartyl protease inhibitors
03/04/2009EP2029517A2 Antiproliferative compounds, compositions and methods of use
03/04/2009EP2029234A1 Treatment of gastrointestinal disorders with cgrp-antagonists
03/04/2009EP2029233A2 Treatment of gastrointestinal disorders with cgrp antagonists
03/04/2009EP2029232A1 Antibacterial extracellular polysaccharide solvating system
03/04/2009EP2029197A2 A system for controlling administration of anaesthesia
03/04/2009EP2029162A1 Composition for controlling snoring, in the form of a nasal spray
03/04/2009EP2029155A2 Improved antitumoral treatments
03/04/2009EP2029152A1 Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
03/04/2009EP2029147A1 Methods for treating cancer
03/04/2009EP2029146A2 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
03/04/2009EP2029145A2 Pyrrolopyrimidine compounds and their uses
03/04/2009EP2029144A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer
03/04/2009EP2029143A2 Substituted 8-[6-amino-3-pyridyl]xanthines
03/04/2009EP2029142A1 Composition for induction or inhibition of stem cell differentiation
03/04/2009EP2029141A2 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist
03/04/2009EP2029140A1 Stable and bioavailable formulations and a novel form of desloratadine
03/04/2009EP2029139A1 Use of a p38 kinase inhibitor for treating psychiatric disorders
03/04/2009EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
03/04/2009EP2029137A2 Antihypertensive therapy method
03/04/2009EP2029136A1 Treatment for depressive disorders
03/04/2009EP2029135A2 Epoxide inhibitors of cysteine proteases
03/04/2009EP2029134A1 Stabilized pharmaceutical compositions comprising fesoterodine
03/04/2009EP2029133A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof
03/04/2009EP2029132A2 Anti-histamine compositions and use thereof
03/04/2009EP2029131A2 Method for treating renal disease
03/04/2009EP2029130A2 Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
03/04/2009EP2029128A2 Method of treatment of chronic nonbacterial prostatitis with selective estrogen receptor modulators or aromatase inhibitors
03/04/2009EP2029127A1 New long-acting drug combinations for the treatment of respiratory diseases
03/04/2009EP2029126A1 Novel medicament combinations for the treatment of respiratory diseases
03/04/2009EP2029125A2 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown
03/04/2009EP2029124A1 Use of gpcr agonists to delay progression of diabetes
03/04/2009EP2029123A2 Use of a compound with rankl activity
03/04/2009EP2029122A2 Autodestructive transdermal therapeutic system
03/04/2009EP2029118A2 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
03/04/2009EP2029114A2 Pharmaceutical compositions for sustained release of phenyephrine
03/04/2009EP2029110A1 Process for preparing spray dried formulations of tmc125
03/04/2009EP2029109A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds
03/04/2009EP2029105A1 Phenylphrine pulsed release formulations and pharmaceutical compositions
03/04/2009EP2029102A1 Opioid combination wafer
03/04/2009EP2029101A2 Type-2 diabetes combination wafer
03/04/2009EP2029100A2 Ache-nmda combination wafer
03/04/2009EP2029099A2 Combination antihypertensive wafer
03/04/2009EP2029097A2 Combination antidepressants wafer
03/04/2009EP2029089A1 O/w emulsion for caring for hands
03/04/2009EP2028938A1 3,4-disubstituted coumarin and quinolone compounds
03/04/2009EP2028937A1 Melatonin agonist treatment
03/04/2009EP2028936A2 Compositions and methods for antibiotic potentiation and drug discovers
03/04/2009EP1928458B1 Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention
03/04/2009EP1869049B1 Imidazopyridazine compounds
03/04/2009EP1836187B1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists
03/04/2009EP1833795B1 Pyridine compounds for the treatment of prostaglandin mediated diseases
03/04/2009EP1784166B1 Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
03/04/2009EP1776343B1 Quinoline derivatives as neurokinin receptor antagonists
03/04/2009EP1765351B1 Protein kinase inhibitors
03/04/2009EP1729777B1 Pharmaceutical composition comprising a salt of mirtazapine
1 ... 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 ... 7860